Scientists Make Old Blood Stem Cells Young Again in Major Anti-Aging Breakthrough

Scientists at the Icahn School of Medicine at Mount Sinai have achieved a remarkable anti-aging breakthrough by successfully reversing the aging process in blood-forming stem cells in mice. The research team discovered that repairing defects in cellular structures called lysosomes can restore aged stem cells to a youthful state, dramatically improving their ability to regenerate blood and immune cells. The findings, published in Cell Stem Cell, point to lysosomal dysfunction as a major driver of stem cell aging.

The study focused on hematopoietic stem cells (HSCs), rare and long-lasting stem cells found in bone marrow that generate all blood and immune cells in the body. As people age, these critical stem cells gradually lose their regenerative capacity, weakening immune defenses and contributing to increased vulnerability to infections seen in older adults. Aging HSCs are also linked to clonal hematopoiesis, a condition that raises the risk of blood cancers and inflammatory diseases.

Researchers led by Professor Saghi Ghaffari discovered that lysosomes in aged HSCs become excessively acidic, damaged, depleted, and abnormally active. Lysosomes function as cellular recycling centers, breaking down proteins and other molecules while storing nutrients for release when needed. The team found that this lysosomal overactivity disrupts both the metabolic balance and epigenetic stability of aging stem cells.

Using single-cell analysis and functional testing, the scientists demonstrated that blocking excessive lysosomal activity with a vacuolar ATPase inhibitor restored lysosomal health and dramatically improved the function of aging blood stem cells. After treatment, the old stem cells began behaving like young, healthy cells again, regaining their ability to regenerate effectively and produce balanced populations of blood and immune cells.

The treated cells showed remarkable improvements across multiple measures of cellular health. They demonstrated enhanced metabolism and mitochondrial performance, healthier epigenetic patterns, reduced inflammation, and fewer harmful inflammatory signals that can damage surrounding tissues. The research suggests that targeting lysosomal dysfunction could represent a promising new approach to combating age-related decline in stem cell function, potentially leading to therapies that could help maintain healthier immune systems and blood production as people age.